Eneida A Santos Michel V F Sucupira Juçara Arabe Selma A Gomes
10.1186/1471-2334-4-29
BMC Infect Dis
2004 Aug 31;4:29.
CC BY
https://pubmed.ncbi.nlm.nih.gov/15339340/
Anti-HIV Agents / therapeutic use HIV Infections / drug therapy HIV-1 Hepatitis B virus / genetics Hepatitis B, Chronic / virology Lamivudine / therapeutic use
Anti-HIV Agents / therapeutic use HIV Infections / drug therapy HIV-1 Hepatitis B virus / genetics Hepatitis B, Chronic / virology Lamivudine / therapeutic use Case Reports Research Support, Non-U.S. Gov't Adult Anti-HIV Agents / pharmacology Cloning, Molecular DNA, Viral / blood DNA, Viral / chemistry DNA-Directed DNA Polymerase / genetics Drug Resistance, Viral / drug effects Drug Resistance, Viral / genetics Fatal Outcome HIV Infections / complications Hepatitis B Surface Antigens / genetics Hepatitis B virus / classification Hepatitis B virus / drug effects Hepatitis B, Chronic / complications Hepatitis B, Chronic / drug therapy Humans Lamivudine / pharmacology Male Mutation / drug effects Phylogeny Polymerase Chain Reaction Anti-HIV Agents DNA, Viral Hepatitis B Surface Antigens Lamivudine DNA-Directed DNA Polymerase
PMC516776
15339340
Hepatitis B virus variants in an HIV-HBV co-infected patient at different periods of antiretroviral treatment with and without lamivudine
2004